Patents by Inventor Kilian Waldemar Conde-Frieboes

Kilian Waldemar Conde-Frieboes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090203581
    Abstract: The present invention relates to novel peptide compounds which are effective in modulating one or more melanocortin receptor types, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of obesity as well as a variety of diseases or conditions associated with obesity.
    Type: Application
    Filed: July 7, 2006
    Publication date: August 13, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Ulrich Sensfuss, Leif Christensen, Jane Spetzler, Kilian Waldemar Conde Frieboes, Henning Thogersen
  • Patent number: 7541430
    Abstract: Novel cyclic and linear peptides of the formula R1—X—X1—X2—X3—X4—X5—X6—X7—X8—X9—X10—X11—R2 are useful in the treatment of obesity are provided.
    Type: Grant
    Filed: November 7, 2005
    Date of Patent: June 2, 2009
    Assignee: Novo Nordisk A/S
    Inventors: Ulrich Sensfuss, Kilian Waldemar Conde Frieboes, Leif Christensen, Ingrid Vivika Petterson, Thomas Kruse Hansen, Michael Ankersen, Kjeld Madsen
  • Patent number: 7517854
    Abstract: Small cyclic peptides of the formula X1-X2-X3-X4-X5-X6-X7-R1 comprising 7-12 amino acid residues are provided. Said peptides are MC4 receptor agonists, and thus useful in the treatment of obesity and related diseases.
    Type: Grant
    Filed: March 30, 2006
    Date of Patent: April 14, 2009
    Assignee: Novo Nordisk A/S
    Inventors: Kilian Waldemar Conde-Frieboes, Ulrich Sensfuss, Kjeld Madsen, Nils Langeland Johansen, Leif Christensen, Thomas Kruse Hansen, Birgitte Schjellerup Wulff
  • Publication number: 20090088388
    Abstract: Novel cyclic and linear peptides of the formula R1—X—X1—X2—X3—X4—X5—X6—X7—X8—X9—X10—X11—R2 are useful in the treatment of obesity are provided.
    Type: Application
    Filed: July 8, 2008
    Publication date: April 2, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Ulrich Sensfuss, Kilian Waldemar Conde Frieboes, Leif Christensen, Ingrid Vivika Petterson, Thomas Kruse Hansen, Michael Ankersen, Kjeld Madsen
  • Publication number: 20080200366
    Abstract: The present invention relates to novel peptide compounds which are effective in modulating one or more melanocortin receptor types, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of obesity as well as a variety of diseases or conditions associated with obesity.
    Type: Application
    Filed: April 7, 2006
    Publication date: August 21, 2008
    Applicant: Novo Nordisk A/S
    Inventor: Kilian Waldemar Conde Frieboes